no scripts enabled
Medikabazaar
Cart
Betrecep 5mg Tablet 14's
Betrecep 5mg Tablet 14's: Image 1
Betrecep 5mg Tablet 14's: Image 2
Betrecep 5mg Tablet 14's: Image 3

Your Advantages

Brand Pfizer

Betrecep 5mg Tablet contains Tofacitinib, a Janus Kinase (JAK) inhibitor, used to treat various autoimmune and inflammatory conditions such as rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and ulcerative colitis.

 

Benefits

This medicine helps reduce pain, tenderness, and swelling in the joints by decreasing inflammation. It also aids in slowing the progression of bone and joint damage, thereby improving the patient's quality of life.

 

Uses and Indications

  • Treatment of moderate to severe rheumatoid arthritis.
  • Treatment of psoriatic arthritis.
  • Treatment of ankylosing spondylitis.
  • Treatment of moderate to severe ulcerative colitis.

The Betrecep 5mg Tablet contains:

  • Tofacitinib 5mg (active ingredient).
Active Ingredient(s)Tofacitinib 5mg
Therapeutic ClassJanus Kinase (JAK) Inhibitor, Disease-Modifying Antirheumatic Drug (DMARD)
Storage ConditionsStore at 20°C to 25°C (68°F to 77°F)
Regulatory ApprovalPrescription Medicine
Licensed IndicationsRheumatoid arthritis, Psoriatic arthritis, Ulcerative colitis, Ankylosing spondylitis
Route of AdministrationOral

Dosage and Administration

  1. Take Betrecep 5mg Tablet as prescribed by your doctor. The dosage depends on your condition and other medications you are taking.
  2. Swallow the tablet whole with water, with or without food.
  3. It is best to take the medicine at the same time each day.
  4. Do not stop taking this medicine unless advised by your doctor, as your condition could worsen.

 

Storage and Disposal

  • Store Betrecep 5mg Tablet at 20°C to 25°C (68°F to 77°F).
  • Keep the medicine in its original packaging to protect it from moisture.
  • Keep out of reach of children.

Precautions and Safety

  • Betrecep 5mg Tablet can increase the risk of infections, including upper respiratory tract infections, herpes zoster (shingles), and tuberculosis.
  • There is an increased risk of blood clots (deep vein thrombosis, pulmonary embolism) and major cardiovascular events (heart attack, stroke), especially in patients aged 50 years or older with cardiovascular risk factors.
  • This medicine is not suitable for children under 18 years old.
  • Avoid taking live vaccines while on this medication.
  • Inform your doctor if you have or have ever had tuberculosis, shingles, kidney or liver disease, hepatitis B or C, or blood clots.
  • Regular blood tests may be required to monitor lymphocyte counts, liver function, kidney function, and cholesterol levels.
  • Do not start treatment if you have any kind of infection.
  • Avoid contact with people who have contagious illnesses like chickenpox, measles, or flu.

 

Side Effects and Risks

  • Common side effects include upper respiratory tract infections, headache, diarrhea, and nasopharyngitis.
  • Other less common but serious side effects can include blood clots and tears in the stomach or intestine wall.
  • Rarely, allergic reactions such as swelling of the lips, tongue, or throat, or hives may occur. Seek urgent medical attention if these symptoms develop.

 

Disclaimer

Use this medicine only under the prescription and guidance of a qualified doctor or pharmacist.

twitterlinkedinfacebookinstagramyoutube
@Copyright Boston Ivy Healthcare Solutions Private Limited